“Cabozantinib-Exposed Renal Cell Carcinoma Organoids Suggest Transcriptomic Associations With Treatment Resistance in Clear Cell and Nonclear Cell Tumors”. Journal of Kidney Cancer 12, no. 2 (May 5, 2025): 37–45. Accessed June 16, 2026. https://www.jkcvhl.com/index.php/jkcvhl/article/view/386.